Lupin Limited (BOM:500257)
India · Delayed Price · Currency is INR 1,925.00
-3.00 (-0.16%)
At close: Oct 23, 2026
Lupin Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 299,666 | 279,580 | 227,079 | 200,108 | 166,417 | 164,055 |
Revenue Growth | 28.19% | 23.12% | 13.48% | 20.24% | 1.44% | 8.19% |
Gross Profit Gross Profit Growth | 216,842 | 199,930 | 153,269 | 128,992 | 94,095 | 95,054 |
Operating Income Operating Income Growth | 75,133 | 68,702 | 41,658 | 27,758 | 8,524 | 12,580 |
Net Income Net Income Growth | 55,288 | 53,328 | 32,816 | 19,145 | 4,301 | -15,280 |
Earnings Per Share EPS Growth | 120.71 | 116.44 | 71.69 | 41.87 | 9.41 | -33.65 |
EPS Growth | 49.41% | 62.42% | 71.22% | 344.95% | - | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Pharmaceuticals Pharmaceuticals Growth | 298,103 | 278,124 | 226,043 | 199,452 | 166,417 | 164,055 |
Others Others Growth | 1,581 | 1,474 | 1,055 | 671.4 | - | - |
Inter Segment Inter Segment Growth | -18.6 | -17.2 | -18.6 | -15.2 | - | - |
Total Total Growth | 299,666 | 279,580 | 227,079 | 200,108 | 166,417 | 164,055 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 78,947 | 78,947 | 29,899 | 20,345 | 17,176 | 19,123 |
Total Debt Total Debt Growth | 66,162 | 66,162 | 54,478 | 29,218 | 45,415 | 41,584 |
Net Cash (Debt) Net Cash Growth | 12,785 | 12,785 | -24,579 | -8,872 | -28,239 | -22,461 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 27.91 | 27.91 | -53.69 | -19.40 | -61.80 | -49.47 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 73,345 | 29,999 | 36,484 | 18,972 | 3,673 |
Capital Expenditures CapEx Growth | - | -20,549 | -16,824 | -9,289 | -14,996 | -9,051 |
Free Cash Flow Free Cash Flow Growth | - | 52,797 | 13,175 | 27,195 | 3,976 | -5,378 |
Free Cash Flow Growth | - | 300.73% | -51.55% | 583.93% | - | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 72.36% | 71.51% | 67.50% | 64.46% | 56.54% | 57.94% |
Operating Margin | 25.07% | 24.57% | 18.34% | 13.87% | 5.12% | 7.67% |
Pretax Margin | 24.94% | 24.58% | 17.68% | 12.10% | 4.31% | -8.36% |
Profit Margin | 18.45% | 19.07% | 14.45% | 9.57% | 2.58% | -9.31% |
FCF Margin | - | 18.88% | 5.80% | 13.59% | 2.39% | -3.28% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 18.000 | 18.000 | 12.000 | 8.000 | 4.000 | 4.000 |
Dividend Per Share Growth | 50.00% | 50.00% | 50.00% | 100.00% | 0% | -38.46% |
Dividend Yield | 0.94% | 0.78% | 0.59% | 0.49% | 0.62% | 0.54% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 15.95 | 19.83 | 28.19 | 38.51 | 68.54 | - |
Forward PE | 20.84 | 22.15 | 24.99 | 31.39 | 19.21 | 14.66 |
P/FCF Ratio | 16.67 | 20.03 | 70.23 | 27.11 | 74.13 | - |
PS Ratio | 2.94 | 3.78 | 4.07 | 3.68 | 1.77 | 2.07 |